28 patients in ITT 200 mg group. 85.7% completed the trial. The way I figured it, 4 dropped out- 1 at 2 weeks, 2 more by 4 weeks, and one more in the last few weeks of the trial. I'm focusing on the data beyond 4 weeks where only 1/25 is lost near the end of the trial.
It's hard not to be encouraged with IGA2/IGA3 trending down and IGA0/IGA1 trending up beyond 4-6 weeks after 3/4 dropouts have already occurred.
Thanks for directing attention to real data. I do believe the data correctly shows 42.8% of ITT 28 (12 patients) achieved IGA0/1 and 55% looks correct for PP. I hope to look at again tomorrow when I'm more awake.